Cervical-Stim is the only osteogenesis stimulator approved by the U.S. Food and Drug Administration (FDA) as a noninvasive, adjunctive treatment option for cervical fusion.1 The device uses pulsed electromagnetic field (PEMF) technology to increase fusion success in patients at high risk for non-fusion. With an overall clinical success rate of 84 percent, Cervical-Stim increases fusion success significantly by 22 percent when used adjunctively to surgery.1,2
Highlights
- The only osteogenesis stimulator approved by the FDA for use in cervical fusion1
- Delivers broad PEMF treatment coverage for multilevel fusion1
- Works effectively when worn over clothing or bracing
- Lightweight, all-in-one unit with no cords allows unrestricted patient mobility during treatment
- Built-in daily monitoring software to track patient compliance
Footnotes
- PMA P030034, December 2004
- Foley K, et al. randomized, prospective, and controlled clinical trial of pulsed electromagnetic field stimulation for cervical fusion. The Spine Journal. 2008 May/June;8:436-442. Full article available at PubMed.gov